These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 24033809

  • 1. Survival after nephroureterectomy for upper tract urothelial carcinoma: a population-based competing-risks analysis.
    Gandaglia G, Bianchi M, Trinh QD, Becker A, Larouche A, Abdollah F, Roghmann F, Tian Z, Shariat SF, Briganti A, Montorsi F, Karakiewicz PI, Sun M.
    Int J Urol; 2014 Mar; 21(3):249-56. PubMed ID: 24033809
    [Abstract] [Full Text] [Related]

  • 2. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA, Novara G, Shariat SF, Gupta A, Matsumoto K, Walton TJ, Fritsche HM, El-Hakim A, Trischler S, Martínez-Salamanca JI, Seitz C, Ficarra V, Zattoni F, Karakiewicz PI, Kassouf W.
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [Abstract] [Full Text] [Related]

  • 3. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
    Aboumohamed AA, Krane LS, Hemal AK.
    J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
    [Abstract] [Full Text] [Related]

  • 4. Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis.
    Rouprêt M, Hupertan V, Seisen T, Colin P, Xylinas E, Yates DR, Fajkovic H, Lotan Y, Raman JD, Zigeuner R, Remzi M, Bolenz C, Novara G, Kassouf W, Ouzzane A, Rozet F, Cussenot O, Martinez-Salamanca JI, Fritsche HM, Walton TJ, Wood CG, Bensalah K, Karakiewicz PI, Montorsi F, Margulis V, Shariat SF, French National Database on Upper Tract Tumors, Upper Tract Urothelial Carcinoma Collaboration.
    J Urol; 2013 May; 189(5):1662-9. PubMed ID: 23103802
    [Abstract] [Full Text] [Related]

  • 5. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database.
    Lughezzani G, Sun M, Perrotte P, Shariat SF, Jeldres C, Budäus L, Latour M, Widmer H, Duclos A, Bénard F, McCormack M, Montorsi F, Karakiewicz PI.
    Urology; 2010 Feb; 75(2):321-7. PubMed ID: 19962727
    [Abstract] [Full Text] [Related]

  • 6. A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma.
    Jeldres C, Sun M, Isbarn H, Lughezzani G, Budäus L, Alasker A, Shariat SF, Lattouf JB, Widmer H, Pharand D, Arjane P, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.
    Urology; 2010 Feb; 75(2):315-20. PubMed ID: 19963237
    [Abstract] [Full Text] [Related]

  • 7. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Roscigno M, Shariat SF, Margulis V, Karakiewicz P, Remzi M, Kikuchi E, Langner C, Lotan Y, Weizer A, Bensalah K, Raman JD, Bolenz C, Guo CC, Wood CG, Zigeuner R, Wheat J, Kabbani W, Koppie TM, Ng CK, Suardi N, Bertini R, Fernández MI, Mikami S, Isida M, Michel MS, Montorsi F.
    J Urol; 2009 Jun; 181(6):2482-9. PubMed ID: 19371878
    [Abstract] [Full Text] [Related]

  • 8. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
    Colin P, Ouzzane A, Pignot G, Ravier E, Crouzet S, Ariane MM, Audouin M, Neuzillet Y, Albouy B, Hurel S, Saint F, Guillotreau J, Guy L, Bigot P, De La Taille A, Arroua F, Marchand C, Matte A, Fais PO, Rouprêt M, French Collaborative National Database on U.U.T.-U.C.
    BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612
    [Abstract] [Full Text] [Related]

  • 9. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
    Isbarn H, Jeldres C, Shariat SF, Liberman D, Sun M, Lughezzani G, Widmer H, Arjane P, Pharand D, Fisch M, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.
    J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
    [Abstract] [Full Text] [Related]

  • 10. Highly predictive survival nomogram after upper urinary tract urothelial carcinoma.
    Jeldres C, Sun M, Lughezzani G, Isbarn H, Shariat SF, Widmer H, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.
    Cancer; 2010 Aug 15; 116(16):3774-84. PubMed ID: 20564085
    [Abstract] [Full Text] [Related]

  • 11. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.
    Lughezzani G, Jeldres C, Isbarn H, Sun M, Shariat SF, Alasker A, Pharand D, Widmer H, Arjane P, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.
    Eur J Cancer; 2009 Dec 15; 45(18):3291-7. PubMed ID: 19615885
    [Abstract] [Full Text] [Related]

  • 12. Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter.
    Jeldres C, Lughezzani G, Sun M, Isbarn H, Shariat SF, Budaus L, Lattouf JB, Widmer H, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.
    J Urol; 2010 Apr 15; 183(4):1324-9. PubMed ID: 20171666
    [Abstract] [Full Text] [Related]

  • 13. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
    Xylinas E, Rink M, Cha EK, Clozel T, Lee RK, Fajkovic H, Comploj E, Novara G, Margulis V, Raman JD, Lotan Y, Kassouf W, Fritsche HM, Weizer A, Martinez-Salamanca JI, Matsumoto K, Zigeuner R, Pycha A, Scherr DS, Seitz C, Walton T, Trinh QD, Karakiewicz PI, Matin S, Montorsi F, Zerbib M, Shariat SF, Upper Tract Urothelial Carcinoma Collaboration.
    Eur Urol; 2014 Jan 15; 65(1):210-7. PubMed ID: 22579047
    [Abstract] [Full Text] [Related]

  • 14. Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Rieken M, Schubert T, Xylinas E, Kluth L, Rouprêt M, Trinh QD, Lee RK, Al Hussein Al Awamlh B, Fajkovic H, Novara G, Margulis V, Lotan Y, Martinez-Salamanca JI, Matsumoto K, Seitz C, Remzi M, Karakiewicz PI, Scherr DS, Briganti A, Bachmann A, Shariat SF, UTUC Collaboration.
    Eur J Surg Oncol; 2014 Dec 15; 40(12):1693-9. PubMed ID: 24780094
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.
    Krambeck AE, Thompson RH, Lohse CM, Patterson DE, Segura JW, Zincke H, Elliott DS, Blute ML.
    J Urol; 2007 May 15; 177(5):1721-6. PubMed ID: 17437796
    [Abstract] [Full Text] [Related]

  • 19. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.
    Kim DS, Lee YH, Cho KS, Cho NH, Chung BH, Hong SJ.
    Urology; 2010 Feb 15; 75(2):328-32. PubMed ID: 20018349
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.